Manufacturers of vital and essential drugs (VED) may be obliged to lower their prices to the level of prices for the same drugs in the countries of the Customs Union. Such proposal is promoted by the Federal Antimonopoly Service (FAS) of Russia as a part of drafting a new decree on state regulation of drug prices. The manufacturers consider the proposal of officials as a form of pressure on businesses and threaten to withdraw from the market.
FAS sent to the Ministry of Health the proposal to establish a rule that would require the manufacturers of VED to reduce the ex-works prices for these drugs, if a lower price is found in the countries of the Customs Union.
The companies would have to reduce the registered prices to the level of minimum prices in the other countries. It is necessary that they themselves announce the reduction of such price in Russia. It is assumed that this would be done every year or every two years, said Nadezhda Sharavskaya, the assistant to Timofey Nizhegorodtsev, the Head of the Department for Control over Social Sphere and Trade at FAS. She added that the companies would have to monitor themselves the prices of competitors within the Union.